Date:
Tuesday, February 7, 2017, 12:00pm to 1:00pm
Location:
Harvard Law School, Wasserstein Hall, Milstein East A (2036), Massachusetts Ave., Cambridge
This event is free and open to the public. Learn more and register at: http://petrieflom.law.harvard.edu/events
Biosimilars are a type of biological product approved by FDA on the basis of being highly similar to an already approved biological reference product. This panel of experts will discuss the current state of biosimilars in the healthcare ecosystem and what comes next from a technical and legal perspective.
Panelists
Jennifer DiGiacinto, RRD International
Robert S. Langer, MIT; Consultant, Eagle Biologics
Benjamin Roin, MIT Sloan School of Management
Moderator: Aaron S. Kesselheim, Brigham and Women’s Hospital/ Harvard Medical School
 | 17.02.07_biosimilars_panel_poster.pdf | 436 KB |